| Business Summary | | Orthofix
International
N.V.
is
engaged
in
the
design,
development,
manufacture,
marketing
and
distribution
of
medical
equipment,
principally
for
the
orthopedic
market.
The
Company's
main
products
are
external
and
internal
fixation
devices
used
in
fracture
treatment,
limb
lengthening
and
bone
reconstruction,
and
pulsed
electromagnetic
frequency
products
used
for
the
non-invasive
healing
enhancement
of
spinal
fusions
and
recalcitrant
bone
fractures.
Other
orthopedic
products
that
the
Company
produces
include
devices
for
the
removal
of
cement
in
hip
revision
procedures,
the
ultrasonic
treatment
of
musculo-skeletal
pain,
bracing
products
and
an
oral-maxillofacial
bone
substitution
compound.
The
Company
also
produces
a
device
for
enhancing
venous
circulation.
Orthofix
has
four
groups
of
products:
Orthopedic
Products,
Stimulation
Products,
Vascular
Therapy
Products
and
Other
Products. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Orthofix
International
is
engaged
in
the
design,
development,
manufacture,
marketing
and
distribution
of
medical
equipment,
principally
external
and
internal
fixation
devices
and
pulsed
electromagnetic
frequency
products
for
non-invasive
healing.
For
the
six
months
ended
6/30/01,
net
sales
rose
19%
to
$79.2
million.
Net
income
fell
72%
to
$10
million.
Results
reflect
increased
market
acceptance
of
new
products,
offset
by
the
absence
of
EBI
litigation
gains. | More
from
Market Guide: Significant
Developments |
| | |
| Position | Robert Cooper, 62 | Chairman | Edgar Wallner, 63 | Pres,
CEO, Director | Peter Hewett, 64 | Vice
Chairman | Peter Clarke, 58 | Exec.
VP, CFO, Sec., Director | Charles Federico, 51 | Sr.
VP, Pres, North America |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|